Noninvasive Sensors of Metabolic Activity

代谢活动的无创传感器

• 批准号: 7337135
• 负责人: John Harris Miller
• 金额: $ 21.95万
• 依托单位: UNIVERSITY OF HOUSTON
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-04 至 2010-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7337135
• 关键词: ATP phosphohydrolase; Adenosine Triphosphate; Adipose tissue; Affect; Behavioral; Body mass index; Cardiovascular Diseases; Cardiovascular system; Cations; Cell membrane; Cells; Charge; Chemicals; Chloroplasts; Clinical; Clinical Data; Complex; Complication; Coronary heart disease; Coupled; Data; Defect; Development; Development, Other; Device or Instrument Development; Devices; Diabetes Mellitus; Diagnostic; Dietary intake; Disease; Disease Outcome; Early Diagnosis; Electrodes; Electron Transport; Energy Metabolism; Enzymes; Epidemic; Evolution; Exhibits; Exploratory/Developmental Grant; Figs - dietary; Frequencies; Functional disorder; Funding; Future; Generations; Goals; Health; Heart Diseases; Hepatocyte; Human; Hyperglycemia; Hyperlipidemia; In Vitro; Individual; Inflammation; Inner mitochondrial membrane; Insulin Resistance; Investigation; Islets of Langerhans; Label; Lead; Life; Life Style; Light; Link; Liver; Malignant Neoplasms; Measurement; Measures; Medical Research; Membrane; Membrane Potentials; Membrane Proteins; Metabolic; Metabolic syndrome; Metabolism; Methods; Mitochondria; Mitochondrial Diseases; Molecular; Molecular Conformation; Monitor; Motion; Multienzyme Complexes; Myocardial Infarction; Myocardium; Noise; Non-Insulin-Dependent Diabetes Mellitus; Numbers; Obesity; Operative Surgical Procedures; Organelles; Organism; Outcome; Overweight; Pancreas; Pathology; Patients; Pharmaceutical Preparations; Physical activity; Physiological; Play; Prevalence; Prevention; Prokaryotic Cells; Public Health; Pump; Range; Rate; Research; Resolution; Respiratory Chain; Rest; Risk; Risk Factors; Role; Serum Markers; Skeletal Muscle; Skeletal system; Smooth Muscle; Spectrum Analysis; Stroke; Structure; Techniques; Technology; Texas; TimeLine; Treatment Effectiveness; Universities; Validation; Vesicle; Weight; Whole Organism; Work; base; clinical application; clinically significant; cost; demographics; design; diet and exercise; electric field; energy balance; improved; in vitro Assay; in vivo; inhibitor/antagonist; innovative technologies; instrument; lead ion; man; mitochondrial dysfunction; nutrition education; oligomycin sensitivity-conferring protein; programs; reconstitution; research and development; respiratory; response; sensor; size; stem; superconductivity; technology development

DESCRIPTION (provided by applicant): The ongoing worldwide obesity epidemic is creating enormous heath consequences, including increased type-2 diabetes, cancer, and heart disease. Metabolic syndrome is a pernicious complication that affects many, but not all, obese individuals and greatly increases the likelihood of such diseases. Although drug treatments exist, the cost to treat all obese individuals would be prohibitive. Therefore, a critical public health need exists for instruments that provide early diagnosis of metabolic syndrome and enable cost-effective treatment. The long-term goal is to develop technologies that detect metabolic activity in humans for research and clinical applications. The chemical currency of energy and metabolism is adenosine triphosphate (ATP), produced by enzyme complexes within mitochondria. Preliminary work suggests that such complexes generate harmonics in response to oscillatory electric fields. The focus of this proposal is to develop sensors, based on harmonic generation spectroscopy, which detect metabolic activity in mitochondria. The specific aims are to: (1) develop sensors that detect activity of mitochondrial complexes in cells in vitro; (2) determine which features of the harmonic spectra correlate with activity of specific enzyme complexes; and (3) assess the viability of detecting metabolic syndrome in obese patients. This approach will enable eventual development of clinical devices that can detect metabolic syndrome early or monitor resting and active metabolism.

描述（由申请人提供）：正在进行的全球肥胖流行病正在造成巨大的健康后果，包括增加2型糖尿病，癌症和心脏病。代谢综合征是一种有害的并发症，影响到许多肥胖者，但不是所有肥胖者，并大大增加了患此类疾病的可能性。虽然有药物治疗，但治疗所有肥胖者的费用将是令人望而却步的。因此，公共卫生迫切需要能够提供代谢综合征早期诊断和具有成本效益的治疗手段。长期目标是开发检测人体代谢活动的技术，用于研究和临床应用。能量和新陈代谢的化学货币是三磷酸腺苷（ATP），由线粒体内的酶复合物产生。初步研究表明，这种复合物在振荡电场的作用下产生谐波。该提案的重点是开发传感器，基于谐波产生光谱，检测线粒体的代谢活动。具体目标是：(1)开发检测体外细胞线粒体复合物活性的传感器；(2)确定谐波光谱的哪些特征与特定酶配合物的活性相关；(3)评估肥胖患者代谢综合征检测的可行性。这种方法将使临床设备的最终发展能够早期检测代谢综合征或监测静息和活跃代谢。